首页 > 抗体蛋白 > 抗体
PE anti-mouse I-A/I-E Antibody
产品名称:
PE anti-mouse I-A/I-E Antibody
产品类别:
抗体
产品编号:
107607
产品应用:
107607
[价格]
规格 价格 库存
50µg ¥ 1104 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Activated C57BL/6 mouse spleen cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The M5/114.15.2 antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes. Clone M5/114.15.2 however does not react wtih I-Af, I-Ak, or I-As MHC class II alloantigens.1

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of frozen sections2,3,6, in vitro and in vivo blocking of antigen presentation or ligand binding4-7, and spatial biology (IBEX)17,18. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 107655 & 107656).

Application References

(PubMed link indicates BioLegend citation)
  1. Bhattacharya A, et al. 1981. J. Immunol. 127:2488. (IP)
  2. Viville S, et al. 1993. Cell 72:635. (IHC)
  3. Nelson AJ, et al. 1993. J. Immunol. 151:2453. (IHC)
  4. Shi Y, et al. 1998. J. Exp. Med. 187:367. (Block)
  5. Yamashita I, et al. 1993. Int. Immunol. 5:1139.
  6. Guo M, et al. 1995. Zygote 3:65. (IHC)
  7. Kim A, et al. 2004. Exp. Mol. Med. 36:428. (Block)
  8. Luckashenak NA, et al. 2006. J. Immunol. 177:5177.
  9. Venanzi ES, et al. 2007. J. Immunol. 179:5693.
  10. Christensen SR, et al. 2006. Immunity 25:417. PubMed
  11. Matte-Martone C, et al. 2008. Blood 111:3884. PubMed
  12. De Pascalis R, et al. 2008. Infect. Immun. 76:4311. PubMed
  13. Kuns RD, et al. 2009. Blood 113:5999. PubMed
  14. Sabatino JJ, et al. 2011. J. Exp. Med. 208:81. PubMed
  15. Draber P, et al. 2011. Mol Cell Biol. 22:4550. PubMed
  16. Fu H, et al. 2014. Nat Commun. 5:3436. PubMed
  17. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  18. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  2. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  3. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  4. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  5. Platt DJ, et al. 2021. Cell Reports. 35(6):109113. PubMed
  6. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  7. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  8. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  9. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  10. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  11. Zhu J, et al. 2016. Sci Rep. 6:27136. PubMed
  12. Yasmin N, et al. 2013. J Exp Med. 210:2597. PubMed
  13. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  14. Cai W, et al. 2020. J Immunol Res. 2019:2835256. PubMed
  15. Gómez-Díaz C, et al. 2021. iScience. 24:103241. PubMed
  16. Christopher S Garris et al. 2018. Immunity. 49(6):1148-1161 . PubMed
  17. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  18. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  19. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  20. Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
  21. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  22. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  23. Jenkins RW, et al. 2018. Cancer Discov. 8:196. PubMed
  24. Dhandapani R, et al. 2018. Nat Commun. 9:1640. PubMed
  25. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  26. Tu J, et al. 2022. Theranostics. 12:747. PubMed
  27. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  28. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  29. Smith AS, et al. 2022. J Immunother Cancer. 10:. PubMed
  30. Zhao H, et al. 2021. Int J Nanomedicine. 16:4913. PubMed
  31. Tuganbaev T, et al. 2020. Cell. 182(6):1441-1459.e21. PubMed
  32. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  33. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  34. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  35. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  36. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  37. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  38. Bambouskova M, et al. 2021. Cell Reports. 34(10):108756. PubMed
  39. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  40. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  41. Liu J, et al. 2020. Nat Commun. 11:6396. PubMed
  42. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  43. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  44. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  45. Morales-Kastresana A, et al. 2020. Curr Protoc Cytom. 95:e81. PubMed
  46. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  47. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  48. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  49. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  50. Pazmandi K, et al. 2014. Free Radic Biol Med. 77:281. PubMed
  51. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  52. Sanchez M et al. 2017. Cell host & microbe. 22(4):543-551 . PubMed
  53. Huang L, et al. 2021. Frontiers in Cellular and Infection Microbiology. 10:606340. PubMed
  54. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  55. Zhao H, et al. 2022. Int J Biol Sci. 18:154. PubMed
  56. Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed
  57. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  58. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  59. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  60. Sü? P, et al. 2020. Cell Reports. 30(12):4082-4095. PubMed
  61. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  62. Cao H, et al. 2020. Front Pharmacol. 11:578943. PubMed
  63. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  64. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  65. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  66. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
RRID
AB_313322 (BioLegend Cat. No. 107607) AB_313323 (BioLegend Cat. No. 107608)

Antigen Details

Structure
MHC class II
Distribution

B cell and activated T cells, APCs of the H-2b,d,q,r bearing mice

Function
Antigen presentation
Ligand/Receptor
CD3/TCR, CD4
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, T cells, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
MHC Antigens
Antigen References

1. Watts C. 1997. Ann. Rev. Immunol. 15:821.
2. Pamer E, et al. 1998. Ann. Rev. Immunol. 16:323.

Gene ID
14961 View all products for this Gene ID 14969 View all products for this Gene ID
UniProt
View information about I-A/I-E on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线